Clinical Trial

Frameless Stereotactic Radiosurgery for Intact Brain Metastases

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a randomized study to determine if not treating planning target volume (PTV) margins during radiation therapy worsens progression free survival rates in patients with brain metastases.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2016-04-19; most recent amendment 2025-12-19.
Status change: Suspended → Recruiting 2025-12-19
Status change: Recruiting → Suspended 2024-12-09
Status change: Not Yet Recruiting → Recruiting 2016-07-15
Trial Details
NCT Number NCT02747303
Lead Sponsor University of Chicago
Conditions Brain Metastases
Enrollment 166 participants
Start Date 2023-09-05
Primary Completion 2028-08-22 (estimated)
Study Completion 2028-08-22 (estimated)
Updated on ClinicalTrials.gov 2025-12-29